March 30

HIV Business Meeting

February 22

CROI 2023 Follow Up Meeting

February 22

FY2022 the 30th CROI; Phase 3 part of Phase 2/3 trial result

January 30

FY2022 3Q Financial Results

November 24

Briefing Session onCOVID-19

November 1

FY2022 2Q Financial Results

October 12

R&D day

August １

FY2022 1Q Financial Results

June 15

Press conference on the conclusion of landmark license and collaboration agreement by GARDP, CHAI and Shionogi

June 10

Goldman Sachs Japan Thought Leaders Forum 2022

May 11

FY2021 Financial Results

April 24

the 32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID); Results from clinical trials of S-217622

March 4

SMBC Nikko Web IR for Retail Investors SMBC Nikko Web IR for Retail Investors

March 4

Briefing session on Phase 2/3 booster trial of COVID-19 vaccine "S-268019"

February 7

Briefing session on COVID-19 therapeutic drug "S-217622"

January 31

3Q Conference Call

November １

FY2021 2Q Financial Results

September 29

R&D Meeting 

September 16

BofA Global Healthcare Conference 2021

August 2

1Q Conference Call

May 11

FY2020 Financial Results

February 1

FY2020 3Q Financial Results

November 2

FY2020 2Q Financial Results

October 13

Briefing Session on the Business of the Joint Venture with Ping An Group

July31

1Q Conference Call

June 1

2030 Vision and Medium-Term Business Plan "Shionogi Transformation Strategy (STS2030)" 

May 12

FY2019 Financial results